Patents by Inventor Lequn ZHAO

Lequn ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981741
    Abstract: Provided are humanized anti-human CD45 antibodies and pharmaceutical compositions including the antibodies.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: May 14, 2024
    Assignee: Actinium Pharmaceuticals, Inc.
    Inventors: Lequn Zhao, Helen Kotanides
  • Publication number: 20240010744
    Abstract: Provided are humanized anti-human CD45 antibodies and pharmaceutical compositions including the antibodies.
    Type: Application
    Filed: September 11, 2023
    Publication date: January 11, 2024
    Inventors: Lequn ZHAO, Helen KOTANIDES
  • Publication number: 20230115257
    Abstract: Embodiments include monoclonal antibodies (mAbs) that recognize SARS-Cov-2 spike protein. The mAbs are capable of distinguishing among variants of the virus. The present disclosure also provides a composition and methods of making and using such a composition for treating, preventing, and/or detecting SARS-CoV-2 infection.
    Type: Application
    Filed: May 17, 2022
    Publication date: April 13, 2023
    Inventors: Brian A. ZABEL, Dan LUO, Ling ZHANG, Vydehi KANNEGANTI, Joyce YU, Sophie YANG, Lequn ZHAO, Hua TU, Xiaomei GE
  • Publication number: 20220372114
    Abstract: The present disclosure provides antibodies that bind to the SARS-CoV-2 spike protein, as well as compositions containing the same, and methods of making and using such a composition for treating, preventing, and/or detecting SARS-CoV-2 infection.
    Type: Application
    Filed: May 17, 2022
    Publication date: November 24, 2022
    Inventors: Brian A. ZABEL, Dan LUO, Ling ZHANG, Vydehi KANNEGANTI, Joyce YU, Sophie YANG, Lequn ZHAO, Hua TU